| Literature DB >> 29882085 |
Marzena Rola-Łuszczak1, Magdalena Materniak-Kornas2, Aneta Pluta2, Katarzyna Podgórska3, Jens Nielsen4,5, Tomasz Stadejek6, Jacek Kuźmak2.
Abstract
Porcine reproductive and respiratory syndrome virus is the cause of reproductive failure in sows and respiratory disease in young pigs, which has been considered as one of the most costly diseases to the worldwide pig industry for almost 30 years. This study used microarray-based transcriptomic analysis of PBMCs from experimentally infected pigs to explore the patterns of immune dysregulation after infection with two East European PRRSV strains from subtype 2 (BOR and ILI) in comparison to a Danish subtype 1 strain (DAN). Transcriptional profiles were determined at day 7 post infection in three tested groups of pigs and analysed in comparison with the expression profile of control group. Microarray analysis revealed differential regulation (> 1.5-fold change) of 4253 and 7335 genes in groups infected with BOR and ILI strains, respectively, and of 12518 genes in pigs infected with Danish strain. Subtype 2 PRRSV strains showed greater induction of many genes, especially those involved in innate immunity, such as interferon stimulated antiviral genes and inflammatory markers. Functional analysis of the microarray data revealed a significant up-regulation of genes involved in processes such as acute phase response, granulocyte and agranulocyte adhesion and diapedesis, as well as down-regulation of genes enrolled in pathways engaged in protein synthesis, cell division, as well as B and T cell signaling. This study provided an insight into the host response to three different PRRSV strains at a molecular level and demonstrated variability between strains of different pathogenicity level.Entities:
Keywords: Host immune response; PRRSV; Pig; Transcriptome analysis
Mesh:
Year: 2018 PMID: 29882085 PMCID: PMC6156768 DOI: 10.1007/s11033-018-4204-x
Source DB: PubMed Journal: Mol Biol Rep ISSN: 0301-4851 Impact factor: 2.316
List of primers used in RT-qPCR
| Gene | Reference sequence ID | Primer sequence (5′–3′) |
|---|---|---|
| β-actin | XM_003357928.2 | F: CTCGATCATGAAGTGCGACGT R: GTGATCTCCTTCTGCATCCTGTC [ |
OAS1 2′-5′-Oligoadenylate synthetase 1, 40/46 kDa | NM_214303.1 | F: CTTTGCATCTTCTGGGAAGC R: AGGCCTGGGTTTCTTGAGTT |
CXCL2 Chemokine (C-X-C motif) ligand 2 | NM_001001861.2 | F: CCCTTGGACATTTTATGTCTTCC R: GGACAGAGCGGAAACACAGT |
Il-8 Interleukin 8 | NM_213867.1 | F: AGGAAAAGTGGGTGCAGAAG R: CCACGGAGAATGGGTTTTTG |
CXCL10 Chemokine (C-X-C motif) ligand 10 | NM_001008691.1 | F: CCACTTTGGGACTTAATCGAAG R: AGAAGCCCACGGAGTAAAGA |
FOS FBJ murine osteosarcoma viral oncogene homolog | AJ132510.1 | F: TTTCCTTCGGCATCAATGT R: CATTCAGACCACCTCAC |
IL-4 Interleukin 4 | NM_214123.1 | F: GACAGGAACCTGAGCAGCA R: TCGTCTTTAGCCTTTCCAAGA |
IFNα Interferon-alpha | NM_001166319.1 | F: CCTGTGCCTGGGAGATC R: CTCCTTCTTCCTGAATCTGTC |
IFNβ Interferon-beta | KF414741.1 | F: CAGTACCTGAAGTCCAAGGA R: CAGTTCCGGAGGTAATCTGT |
B-actin primers were designed as described by Duvigneau et al. [20]
Overview of differential gene expression in PBMCs of pigs infected with DAN, ILI and BOR PRRSV strains in regard to PBMCs from mock-infected pigs (FC ≥ 1.5, p-value = 0.05)
| Number of genes | Groups | ||
|---|---|---|---|
| DAN | ILI | BOR | |
| Differentially expressed | 12,518 | 7335 | 4253 |
| UP-regulated | 6033 | 3795 | 2030 |
| DOWN-regulated | 6485 | 3540 | 2223 |
Fig. 1Overview of up-regulated transcripts in DAN (red), BOR (blue) and ILI (green) groups. The numbers in the circles correspond to the number of particular transcripts. Figure was created using the GeneSpring GX10 expression analysis software Agilent Technologies. (Color figure online)
Fig. 2Overview of down-regulated transcripts in DAN (red), BOR (blue) and ILI (green) groups. The numbers in the circles correspond to the number of particular transcripts. Figure was created using the GeneSpring GX10 expression analysis software Agilent Technologies. (Color figure online)
Top canonical pathways of up-regulated genes as demonstrated by interactive pathway analysis (IPA)
| DAN | ILI | BOR |
|---|---|---|
1. Acute phase response signaling 8.43E−11a, 36/169 (0.213)b | 1. Agranulocyte adhesion and diapedesis 2.21E−16, 40/189 (0.212) | 1. Agranulocyte adhesion and diapedesis 3.52E−12, 27/189 (0.143) |
2. FXR/RXR activation 1.78E−10, 30/126 (0.238) | 2. Granulocyte adhesion and diapedesis 3.93E−12, 33/177 (0.186) | 2. Integrin signaling 2.81E−09, 25/219 (0.114) |
3. Agranulocyte adhesion and diapedesis 9.04E−08, 33/189 (0.175) | 3. Leukocyte extravasation signaling 1.81E−09, 32/210 (0.152) | 3. Granulocyte adhesion and diapedesis 5.19E−09, 22/177 (0.124) |
4. LXR/RXR activation 1.18E−07, 25/121 (0.207) | 4. Interferon signaling 2.82E−09, 13/36 (0.361) | 4. Leukocyte extravasation signaling 5.71E−09, 24/210 (0.114) |
5. Tight junction signaling 1.81E−07, 30/167 (0.18) | 5. iNOS signaling 4.52E−08, 13/44 (0.295) | 5. ILK signaling 7.14E−09, 23/196 (0.117) |
ap-Value
bPathway ratio
Top canonical pathways of down-regulated genes as demonstrated by interactive pathway analysis (IPA)
| DAN | ILI | BOR |
|---|---|---|
1. Glucocorticoid receptor signaling 1.24E−12a, 57/287 (0.199)b | 1. Integrin signaling 4.39E−06, 23/219 (0.105) | 1. EIF2 signaling 1.56E−10, 26/194 (0.134) |
2. Regulation of eIF4 and p70S6K signaling 3.70E−12, 39/157 (0.248) | 2. Glucocorticoid receptor Signaling 5.45E−06, 27/287 (0.094) | 2. Regulation of eIF4 and p70S6K signaling 2.38E−07, 19/157 (0.121) |
3. mTOR signaling 1.56E−10, 42/199 (0.211) | 3. EIF2 signaling 7.08E−06, 21/194 (0.108) | 3. mTOR signaling 2.29E−06, 20/199 (0.101) |
4. Production of nitric oxide and reactive oxygen species in macrophages 8.85E−09, 38/193 (0.197) | 4. Regulation of eIF4 and p70S6K signaling 1.44E−05, 18/157 (0.115) | 4. Cell cycle: G1/S checkpoint regulation 6.08E−04, 8/64 (0.125) |
5. EIF2 signaling 1.03E−08, 38/194 (0.196) | 5. Adipogenesis pathway 9.61E−05, 15/134 (0.112) | 5. Antiproliferative role of TOB in T cell signaling 9.08E−04, 5/26 (0.192) |
ap-Value
bPathway ratio
Top canonical pathways of up-regulated genes involved in immunological processes as demonstrated by interactive pathway analysis (IPA)
| DAN | ILI | BOR |
|---|---|---|
1. Acute phase response signaling 1.94E−05a, 19/200 (0.095)b | 1. Agranulocyte adhesion and diapedesis 8.29E−10, 43/189 (0.228) | 1. Agranulocyte adhesion and diapedesis 3.52E−12, 27/189 (0.143) |
2. Agranulocyte adhesion and diapedesis 1.95E−05, 15/133 (0.113) | 2. Granulocyte adhesion and diapedesis 1.28E−07, 37/177 (0.209) | 2. Granulocyte adhesion and diapedesis 5.19E−09, 22/177 (0.124) |
3. Interferon signaling 5.66E−05, 17/180 (0.308) | 3. Leukocyte extravasation signaling 3.07E−07, 39/198 (0.197) | 3. Leukocyte extravasation signaling 5.71E−09, 24/210 (0.114) |
4. Clathrin-mediated endocytosis signaling 2.22E−04, 10/81 (0.123) | 4. iNOS signaling 1.29E−06, 15/44 (0.341) | 4. Production of nitric oxide and reactive oxygen species in macrophages 1.2E−07, 21/193 (0.109) |
5. Production of nitric oxide and reactive oxygen species in macrophages 3.19E−05, 28/193 (0.145) | 5. Interferon signaling 1.48E−06, 13/34 (0.382) | 5. Caveolar-mediated endocytosis signaling 5.82E−07, 12/71 (0.169) |
ap-Value
bPathway ratio
Top canonical pathways of down-regulated genes involved in immunological processes as demonstrated by interactive pathway analysis (IPA)
| DAN | ILI | BOR |
|---|---|---|
1. Production of nitric oxide and reactive oxygen species in macrophages 8.85E−08a, 38/193 (0.197)b | 1. Regulation of IL-2 expression in activated and anergic T lymphocytes 5.16E−04, 10/79 (0.127) | 1. Antiproliferative role of TOB in T cell signaling 9.08E−04, 5/26 (0.192) |
2. B cell receptor signaling 2.97E−08, 36/185 (0.195) | 2. PI3K signaling in B lymphocytes 7.06E−04, 13/128 (0.102) | 2. PI3K signaling in B lymphocytes 5.04E−03, 10/128 (0.078) |
3. IL-15 signaling 4.69E−08, 21/76 (0.276) | 3. NF-κB signaling 8.02E−04, 16/180 (0.089) | 3. Production of nitric oxide and reactive oxygen species in macrophages 1.33E−02, 12/193 (0.062) |
4. NF-κB signaling 4.7E−08, 35/180 (0.194) | 4. B cell receptor signaling 1.07E−03, 16/185 (0.086) | 4. T helper cell differentiation 1.91E−02, 6/71 (0.085) |
5. CD40 signaling 7.68E−08, 21/78 (0.269) | 5. CD40 signaling 1.89E−03, 9/78 (0.115) | 5. B cell receptor signaling 2.33E−02, 11/185 (0.059) |
ap-Value
bPathway ratio
Fig. 3IPA comparison analysis of canonical signaling pathways activation state induced by BOR, ILI and DAN infection. Pathways shaded orange were up-regulated, in blue were down-regulated, in white are those which did not yield any changes in activity. Range of activation z-score is also depicted in the figure. (Color figure online)
Comparison of gene expression changes observed in microarray analysis and RT-qPCR
| Gene | PRRSV strain | Fold change | |
|---|---|---|---|
| Microarray | RT-qPCR | ||
| OAS1 | DAN | 24.12 | 10.17 |
| ILI | 26.91 | 50.88 | |
| BOR | 35.24 | 72.11 | |
| CXCL2 | DAN | − 2.49 | − 3.85 |
| ILI | 2.93 | 9.57 | |
| BOR | 5.46 | 4.28 | |
| Il-8 | DAN | − 2.75 | − 3.70 |
| ILI | 2.24 | 1.25 | |
| BOR | 5.33 | 1.70 | |
| CXCL10 | DAN | 12.28 | 24.34 |
| ILI | 10.30 | 28.06 | |
| BOR | 18.80 | 15.49 | |
| FOS | DAN | − 2.90 | − 5.32 |
| ILI | − 2.10 | − 2.40 | |
| BOR | − 3.49 | − 2.13 | |
| IL-4 | DAN | − 3.89 | − 5.70 |
| ILI | − 3.22 | − 15.60 | |
| BOR | − 2.04 | − 18.50 | |